252 related articles for article (PubMed ID: 7518353)
1. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
[TBL] [Abstract][Full Text] [Related]
2. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
Combaret V; Coll JL; Favrot MC
Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
[TBL] [Abstract][Full Text] [Related]
3. CD44 expression and modulation on human neuroblastoma tumours and cell lines.
Gross N; Beck D; Beretta C; Jackson D; Perruisseau G
Eur J Cancer; 1995; 31A(4):471-5. PubMed ID: 7576948
[TBL] [Abstract][Full Text] [Related]
4. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
Gross N; Balmas Bourloud K; Brognara CB
Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
[TBL] [Abstract][Full Text] [Related]
5. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
6. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
7. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
8. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
[TBL] [Abstract][Full Text] [Related]
9. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
10. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
[TBL] [Abstract][Full Text] [Related]
11. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
Sarkar AK; Nuchtern JG
Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
14. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
15. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Ferrandis E; Da Silva J; Riou G; Bénard I
Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
[TBL] [Abstract][Full Text] [Related]
16. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
Rall CJ; Rustgi AK
Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
[TBL] [Abstract][Full Text] [Related]
17. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
Kavallaris M; Gardaneh M; Cheung B; Camacho ML; Hocker JE; Norris MD; Haber M; Marshall GM
Anticancer Res; 1998; 18(3A):1793-7. PubMed ID: 9673406
[TBL] [Abstract][Full Text] [Related]
20. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
